| Detailed information |
|---|
| CancerLivER ID | 2232 |
| Biomarker | CCAT2 |
| Biomarker Name/Symbol (given in Publication) | CCAT2 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | CCAT2 functions as a oncogene in HCC; but not validated on independent patient cohort |
| Experimental Condition | HCC v/s Normal |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 27347113 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 50 Paired HCC and non-tumor HCC tissue samples were obtained from 50 patients; HCC cell lines (HepG2, HEP3B, HCCLM3 and HuH7) and one normal liver cell line (L02) |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2016 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |